Table 2. Descriptive statistics of psilocybin sessions (n = 409).
| Characteristics | Valuesa | Missings |
| Psilocybin dose (µg/kg) | 214.1 63.0 |
0% |
| Psilocybin dose (categorized) | 0% | |
| 115–125 µg/kg | 23% (93) | |
| 170 µg/kg | 9% (35) | |
| 215–225 µg/kg | 20% (83) | |
| 250–270 µg/kg | 38% (157) | |
| 315 µg/kg | 10% (41) | |
| Time of assessmentb | 0% | |
| 60–90 min | 23% (96) | |
| 110–160 min | 39% (158) | |
| 195–270 min | 23% (94) | |
| 6–10 h | 13% (53) | |
| 24 h | 2% (8) | |
| Setting | 0% | |
| PETc | 12% (51) | |
| no PET | 88% (358) |
a
Means 
standard deviations and frequencies are shown for continuous and categorical variables, respectively. Numbers in parenthesis indicate absolute frequencies.
b
Completion of OAV or 5D-ASC questionnaire after drug intake.
c
Drug sessions involving positron emission tomography (PET) measurements.